ONCAP Invests in Biomerics; Biomerics Merges with Precision Concepts Medical
May 17, 2023
ONCAP (Onex) has made a significant investment in Biomerics and is merging the medical business of Precision Concepts (Precision Concepts Medical) into Biomerics. The transaction, completed with participation from Biomerics' founder Travis Sessions, current shareholder Wasatch Equity Partners and the Marino family, creates a larger vertically integrated medical device contract manufacturer with expanded capabilities and scale to pursue further strategic M&A.
- Buyers
- ONCAP (Onex), Wasatch Equity Partners, Travis Sessions, Marino family
- Targets
- Biomerics, Precision Concepts Medical (medical business of Precision Concepts Group)
- Sellers
- Precision Concepts, Marino family
- Industry
- Medical Devices
- Location
- Utah, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Biomerics Acquires Dependable Plastics, Launches Interventional Medical Plastics Division
July 11, 2022
Medical Devices
Biomerics acquired Dependable Plastics and launched a new Interventional Medical Plastics (IMP) Division to expand its plastic component capabilities for the interventional and robotic-assisted surgery markets. The acquisition adds thermoforming, liquid cast resin molding and additive manufacturing capabilities and establishes operations in Fairfield, California alongside Biomerics' Salt Lake City operations.
-
Medbio (Graham Partners) Acquires Polymer Conversions
September 1, 2020
Medical Devices
Graham Partners’ portfolio company Medbio, an outsourced medical device manufacturer based in Grand Rapids, Michigan, has acquired Polymer Conversions, Inc., a Western New York contract molder. The add‑on expands Medbio’s geographic footprint and injection‑molding and assembly capabilities, creating cross‑selling opportunities and expected operational synergies for the combined medical‑device manufacturing platform.
-
Chimerix Acquires Oncoceutics
January 7, 2021
Biotechnology
Chimerix (NASDAQ: CMRX) acquired clinical-stage Oncoceutics, gaining the late-stage oncology candidate ONC201 to expand its oncology pipeline. The deal closed January 7, 2021, for $78 million (half stock, half cash) plus potential milestones and royalties.
-
ONCAP (Onex) Invests in Ideal Dental Management Partners
July 5, 2022
Healthcare Services
ONCAP, the mid-market private equity platform of Onex Corporation, has made a significant investment in Ideal Dental Management Partners in partnership with the company's affiliated doctors. Ideal Dental is a specialty dental service organization that supports independent specialty dental practices across the U.S. West Coast; ONCAP said it will help accelerate Ideal Dental's organic and inorganic growth plans.
-
Genomate Health Acquires Oncompass Medicine
January 14, 2026
Healthcare Services
Genomate Health, a Cambridge-based precision medicine company, has acquired Hungarian personalized oncology firm Oncompass Medicine to expand its precision-oncology offerings and establish a stronger presence in Europe. The acquisition brings Oncompass's oncology decision‑support capabilities and customer relationships into Genomate's computational precision‑medicine platform.
-
ONCAP Acquires Majority Stake in Merrithew International
February 17, 2022
Consumer Products
ONCAP, the mid-market private equity platform of Onex, has purchased a majority stake in Merrithew International Inc., the Toronto-based developer, manufacturer and retailer of Pilates equipment, accessories, content and education. The investment (from ONCAP IV) was made in partnership with Merrithew founders Lindsay and Moira Merrithew to support the company's continued global growth and expansion through organic initiatives and acquisitions; terms were not disclosed.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.